Charting Tau Modifications as Alzheimer’s Advances
Alz ForumNew research maps how tau changes as Alzheimer’s progresses, identifying soluble tau modifications that could offer new biomarkers of tangle burden.
Research News
ISTAART Launches Two New Professional Interest Areas
Alzheimer's AssociationISTAART launches two new PIAs on physical activity and post-traumatic neurodegeneration. Join now to connect, collaborate and shape dementia research.
AAIC 2026 London: Podcast Conference Highlights
Dementia ResearcherCatch up on AAIC 2026 with four daily podcasts featuring 10 guests sharing the research, conversations and conference moments that caught their attention.
Brain’s Immune Cells Rein in Alzheimer’s Brain Circuits
Suppressing microglia worsened abnormal brain activity and seizures in an Alzheimer’s mouse model, revealing their role in keeping neural circuits stable.
Wellcome Moves Major Funding Schemes to Rolling Applications
Wellcome TrustWellcome is removing fixed deadlines from three major funding schemes, allowing researchers to submit applications whenever they are ready.
Tau Studies Point to New Alzheimer’s Tests and Treatments
The CELIA trial found diranersen reduced tau and showed signs of slowing decline, while separate research linked blood tau with future Alzheimer’s risk.
Blood Test May Predict Alzheimer’s Risk 10 Years Early
A blood test measuring p-tau217 may predict Alzheimer’s-related cognitive decline up to a decade before symptoms appear, AAIC 2026 research finds.
Alzheimer’s Blood Test Could Transform Diagnosis
New data suggest an Alzheimer’s blood test could help primary care doctors diagnose the disease with around 90% accuracy, matching specialists. #AAIC26
LiBBY Trial: THC/CBD Reduces End-of-Life Agitation
Phase 2 LiBBY trial results suggest a THC/CBD combination rapidly and significantly reduces agitation in hospice-eligible people with dementia. #AAIC26
PROTECT-Cog Tests Lifestyle and GLP-1 for Cognitive Decline
A new $100m global trial will test whether combining lifestyle support with GLP-1 or similar drugs can reduce cognitive decline and dementia risk.
Lifestyle Programme Boosts Brain Health Across Latin America
Lifestyle changes improved memory and thinking in older adults at risk of dementia across Latin America, with coaching delivering the strongest gains.
Former Elite Soccer Players Show Evidence of Brain Health Changes in Mid-Life
Research presented by Caleigh Grace Lynch presneted at AAIC provides insights into brain health among former elite professional soccer players during midlife.